 |
 |
NINDS Seeks Newly Diagnosed Parkinson's Disease Patients Investigators at the National Institute of Neurological Disorders and Stroke (NINDS) are seeking newly diagnosed Parkinson's disease patients for a neuroprotective trial involving a new free radical scavenger drug aimed at stopping the progression of the disease. The study will be a two year outpatient trial requiring quarterly visits to the NIH in Bethesda, MD, and more frequent safety visits to a local physician. <Opinion Mode ON> I wonder how long it will take researchers to determine that Parkinson's is a disease that exists outside the beltway? Grants should also include expenses for the researchers to go to the patients where ever they may be. <Opinion Mode OFF> John Cottingham [log in to unmask]